User profiles for Wendy Young
Wendy YoungRoyal Roads University Verified email at royalroads.ca Cited by 1132 |
Total synthesis of baccatin III and taxol
SJ Danishefsky, JJ Masters, WB Young… - Journal of the …, 1996 - ACS Publications
An intramolecular Heck reaction (90 → 91) serves as the key step in the total synthesis of the
titled compounds. The synthetic route is based on utilizing the Wieland−Miescher ketone (5…
titled compounds. The synthetic route is based on utilizing the Wieland−Miescher ketone (5…
Discovery of GDC-0853: a potent, selective, and noncovalent Bruton's tyrosine kinase inhibitor in early clinical development
Bruton’s tyrosine kinase (Btk) is a nonreceptor cytoplasmic tyrosine kinase involved in B-cell
and myeloid cell activation, downstream of B-cell and Fcγ receptors, respectively. …
and myeloid cell activation, downstream of B-cell and Fcγ receptors, respectively. …
Macroflux® microprojection array patch technology: a new and efficient approach for intracutaneous immunization
JA Matriano, M Cormier, J Johnson, WA Young… - Pharmaceutical …, 2002 - Springer
Purpose. We evaluated the Macroflux® microprojection array patch technology as a novel
system for intracutaneous delivery of protein antigens. Methods. Macroflux® microprojection …
system for intracutaneous delivery of protein antigens. Methods. Macroflux® microprojection …
A total synthesis of taxol
…, JT Link, LB Snyder, WB Young… - … Edition in English, 1995 - Wiley Online Library
Taxol (1) is a clinically useful antitumor agent. First approved for the treatment ofovarian
cancer. it is currently being evaluated for efficacy against a broader range of tumors.['l The …
cancer. it is currently being evaluated for efficacy against a broader range of tumors.['l The …
Synthesis of (.+-.)-ferruginine and (.+-.)-anhydroecgonine methyl-ester by a tandem cyclopropanation/Cope rearrangement
HML Davies, E Saikali, WB Young - The Journal of Organic …, 1991 - ACS Publications
Rhodium (II) acetate catalyzed decomposition of vinyldiazomethanes in the presence of iV-(alkoxycarbonyDpyrroles
led to the synthesis of 8-azabicyclo [3.2. 1] octa-2, 6-dienes. The …
led to the synthesis of 8-azabicyclo [3.2. 1] octa-2, 6-dienes. The …
[HTML][HTML] Specific Btk inhibition suppresses B cell–and myeloid cell–mediated arthritis
…, BL Staker, JA Whitney, S Yeh, WB Young… - Nature chemical …, 2011 - nature.com
Bruton's tyrosine kinase (Btk) is a therapeutic target for rheumatoid arthritis, but the cellular
and molecular mechanisms by which Btk mediates inflammation are poorly understood. Here …
and molecular mechanisms by which Btk mediates inflammation are poorly understood. Here …
Aluminum concentrations in drinking water and risk of Alzheimer's disease
…, DN Coggon, H Inskip, RF Lacey, WF Young - …, 1997 - journals.lww.com
To investigate the relation of aluminum and silicon in drinking water to risk of Alzheimer's
disease, we carried out a case-control study in eight regions of England and Wales. Subjects …
disease, we carried out a case-control study in eight regions of England and Wales. Subjects …
Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study
…, B Weller, W Whiteley, I Whittle, R Will, W Young… - Stroke, 2015 - Am Heart Assoc
Background and Purpose— The characteristics of intracerebral hemorrhage (ICH) may vary
by ICH location because of differences in the distribution of underlying cerebral small vessel …
by ICH location because of differences in the distribution of underlying cerebral small vessel …
Battling Btk mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations
…, M Lin, P Bergeron, JJ Crawford, WB Young - ACS chemical …, 2016 - ACS Publications
The Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib has shown impressive clinical efficacy
in a range of B-cell malignancies. However, acquired resistance has emerged, and second …
in a range of B-cell malignancies. However, acquired resistance has emerged, and second …
Discovery of XEN907, a spirooxindole blocker of NaV1. 7 for the treatment of pain
…, S Liu, J Sun, V Raina, R Chui, W Young… - Bioorganic & medicinal …, 2011 - Elsevier
Starting from the oxindole 2a identified through a high-throughput screening campaign, a
series of Na V 1.7 blockers were developed. Following the elimination of undesirable structural …
series of Na V 1.7 blockers were developed. Following the elimination of undesirable structural …